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ABSTRACT
The multi-protein complex WRAD, formed by WDR5,
RbBP5, Ash2L and Dpy30, binds to the MLL SET do-
main to stabilize the catalytically active conformation
required for histone H3K4 methylation. In addition,
the WRAD complex contributes to the targeting of
the activated complex to specific sites on chromatin.
RbBP5 is central to MLL catalytic activation, by mak-
ing critical contacts with the other members of the
complex. Interestingly its only major structural do-
main, a canonical WD40 repeat -propeller, is not im-
plicated in this function. Here, we present the struc-
ture of the RbBP5 -propeller domain revealing a dis-
tinct, feature rich surface, dominated by clusters of
Arginine residues. Our nuclear magnetic resonance
binding data supports the hypothesis that in addi-
tion to the role of RbBP5 in catalytic activation, its
-propeller domain is a platform for the recruitment
of the MLL complexes to chromatin targets through
its direct interaction with nucleic acids.
INTRODUCTION
The novel motifs generated by methylation of histone lysine
residues recruit effector proteins through selective recog-
nition domains and therefore drive the cells gene expres-
sion program (1,2). This process must be tightly controlled,
which is reflected in the complexity of the trithorax and
polycomb methyltransferase complexes that regulate gene
activation and repression through histone H3 lysine-4 and
lysine-27 methylation respectively (3,4). In addition to their
catalytic domains, these complexes contain components
that allosterically regulate enzyme activity and others that
precisely target the enzyme activity to specific genes (5,6).
In higher organisms, histone H3 lysine-4 (H3K4) methyla-
tion is carried out by a family of six large multi-domain en-
zymes, the Mixed Lineage Leukemia (MLL) family. These
enzymes share a distinctive C-terminal catalytic SET do-
main, which is activated by binding to a conserved four-
member complex, termedWRAD (7,8). WRAD consists of
two -propeller domain proteins, WDR5 and RbBP5, the
SPRY/DNA binding domain protein Ash2L and Dpy30
(9). Of these, WDR5, RbBP5 and Ash2L have been shown
to be essential for catalytic activation and are thought to sta-
bilize the active conformation of the SET domain (10,11).
Dpy30 may further modulate this activity although the
molecular details remain to be elucidated (12).
TheMLL family are large proteins, with themajor part of
the sequence composed of many so-called reader domains,
linked by regions of predicted low structural complexity.
The function of the reader domains is to target the enzyme
by recognition of chromatin or other factors (13). For exam-
ple, the PHD3-Bromo cassette of MLL1, binds to its own
product––methylated H3K4, and facilitates the spread of
the activating mark (14). Members of the WRAD complex
have also been shown to bind directly to factors that tar-
get MLL. For example, the WDR5 -propeller can bind to
unmodified histone H3 (15), Ash2L binds directly to the
transcription factors Mef2 and Sox2, and Dpy30 to Oct4
(16,17). In addition to these protein: protein interactions
there is mounting evidence of lncRNA-mediated MLL re-
cruitment to specific loci in chromosomes for gene activa-
tion (18–20). The details of these interactions are unchar-
acterized, but one RNA binding interface has been identi-
fied on the WDR5 -propeller and confirmed by mutation
of key residues that disrupted normal H3K4 methylation
pathways in cells (21). In this manuscript we explore the po-
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tential of the RbBP5 -propeller as another site of RNA
interaction.
The amino terminus of RbBP5, residues 1–325, is com-
posed of a series of canonical WD40 repeats that are pre-
dicted to form a seven bladed -propeller domain, which
is the major structural feature of the protein (Figure 1A).
However, it is the region immediately following this domain,
residues 340–380, that stimulates methyltransferase activity
through cooperative interactions with the other members of
WRAD complex and the MLL SET domain. Specifically,
the region RbBP5344–360 binds to Ash2L (22), RbBP5372–381
to WDR5 (23,24) and RbBP5330–344 to the MLL SET do-
main (11). Thus, only a small 40 amino acid region has
an ascribed function, and the role of the -propeller do-
main and the remaining 150 C-terminal residues of RbBP5
is currently unknown. Here we focus on the RbBP5 -
propeller domain and show that although it is not essential
for WRAD-mediated MLL methyltransferase stimulation,
it potentially has a role in targeting the MLL complex. We
present the first crystal structure of the -propeller domain
and, supported by nuclear magnetic resonance (NMR)
spectroscopy, propose a targeting function through binding
of nucleic acid.
MATERIALS AND METHODS
Protein expression and purification
The mouse RbBP5 gene (residues 1–380) was cloned into
the pOPINS vector for protein production in Escherichia
coli BL21 (DE3) cells (24). The 5′ end of RbBP5 gene was
extended with sequences encoding a 6×His-SUMO tag fol-
lowed by a Precission 3C protease site (L-E-V-L-F-Q-G-
P). RbBP5 (1–380) expression was performed in E. coli
BL21 (DE3) cells, grown in TB media. RbBP5 (1–322) and
RbBP5 (1–340) constructs were generated by introducing a
stop codon at the respective sites in RbBP5 (1–380) by site-
directedmutagenesis. Site directed arginine to glutamic acid
mutants were made in the RbBP5 (1–340) construct. Pro-
tein production was induced at OD600 of 0.8 with 0.2 mM
Isopropyl-D-1-thiogalactopyranoside (IPTG) for 16–20 h
at 20◦C. Harvested cell pellets were resuspended in 50 mM
Tris–HCl (pH 7.4), 150 mM NaCl, 10% glycerol, 0.5 mM
tris(2-carboxyethyl)phosphine (TCEP), 25 g/ml DNaseI,
protease inhibitor cocktail (Sigma) and cells were lysed by
sonication on ice. Unbroken cells and cell debris were re-
moved by centrifugation at 20 000 rpm (Sorvall SS-34 rotor)
for 60min at 4◦C and cleared lysate was loaded onto aNi2+-
NTA gravity flow column containing 3 ml resin (Qiagen).
The resin was washed with 10 column volumes of buffer
containing 20mM imidazole and incubated with rhinovirus
3C protease overnight at 4◦C. Untagged RbBP5 was sepa-
rated from the 6×His-SUMO tag bound toNi2+-NTA resin
by gravity flow. RbBP5 was finally purified by gel filtration
(Superdex 75, GEHealthcare) in 50mMTris/HCl (pH 7.4),
150 mM NaCl, 0.5 mM TCEP and 10% glycerol and the
fractions of the homogenous main peak corresponding to
monomeric RbBP5 were pooled. Purified RbBP5 was snap-
frozen in liquid nitrogen and stored at −80◦C. The RbBP5
(1–340) construct for NMR was expressed in E. coli BL21
(DE3) cells in minimal media with 15NH4Cl2 sole as nitro-
gen source and purified by affinity and size-exclusion chro-
matography as described above.
Crystallization
Crystals of RBBP5 (1–380) were obtained using the vapor
diffusionmethod. RbBP5 (1–380) protein was concentrated
to 15–20 mg/ml and used for crystallization by sitting-drop
method. Initial crystals appeared in 0.1M MES (pH 6.5),
40% polyethylene glycol (PEG) 200 (V/V) (A7 condition of
PEGs suite from Qiagen) at 20◦C. The optimized condition
included a mixture of additives (H3 of Silver Bullet from
HamptonResearch) to the original condition. Crystals were
harvested directly from the drop and flash-frozen in liquid
nitrogen.
Structure determination
Data were collected at the Diamond Light Source (Ox-
fordshire, UK) on station I02. The reflections were indexed
using XDS and reduced/scaled with programs from the
CCP4i suite (25). The structure was solved by molecular re-
placement using the PHASERpackage using edited coordi-
nates of WDR5. Difference maps were used to rebuild and
extend the initial model using the Coot molecular graphics
package (26). Iterative cycles of refinement were carried out
using REFMAC (27). Structure visualization was carried
out in the PyMolMolecular Graphics System (Schrodinger
LLC). Electrostatic surfaces were generated using theAPBS
plugin (28), protein prepared using pdb2pqr (29), map cal-
culated with grid spacing 0.5 and a solvent excluded surface
generated. Conservation was potted onto the surface using
the AL2CO sequence conservation analysis server (30), us-
ing the multiple sequence analysis presented in Supplemen-
taryFigure S2. The coordinates and structure factors for the
structure have been deposited in the PDB under accession
code 5OV3.
RNA preparation
All RNAs pools were purchased from Thermo Scientific
(Dharmacon). Pools were de-protected following the man-
ufacturer instructions and re-suspended in H2O.
NMR spectroscopy
NMR data were acquired using a Bruker NMR spectrome-
ter operating at 800 and 950MHz. NMR samples consisted
of 40–50 M 15N-labeled RbBP5(1–340) alone and in com-
plexwith unlabeledRNAat a 1:1 or 1:4 protein:RNAmolar
ratio, and were prepared in 350 l of NMR buffer (10 mM
Tris–HCl, 75 mM NaCl, pH 7.2 10% D2O). RbBP5–RNA
interaction measurements by HSQCNMRwere performed
at 37◦C. To measure Arginine-side chains experiments were
performed at lower pH (pH 6.9 at room temperature). The
scaffold independent analysis (SIA) strategy and analysis
was as previously described (31), using a pool of 6mer nu-
cleotides.
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Figure 1. RbBP5 architecture and activity. (A) Schematic representation of the RbBP5 protein. The WD40 repeats are indicated along with the three
regions shown to interact with the MLL1 SET domain, Ash2L SPRY domain and WDR5. The bars beneath represent the constructs used in the current
study. (B) Normalized in vitro methyltransferase assay with H3 peptide substrate for the MLL1 (SET domain) + WDR5 + Ash2L (SPRY domain) with
different RbBP5 constructs showing that only the RbBP5 340–380 region is essential for activity. (C) In vitro methyltransferase assay with recombinant
mononucleosome substrate (147 bpDNA), using a histone H3K4monomethyl antibody to follow activity. The loading control gel, stained with Coomassie
Blue, is presented in Supplementary Figure S1. (D) Methyltransferase assay with MLL1 (SET domain) + WDR5 + Ash2L (SPRY domain) with RbBP5
construct plus and minus  propeller analysed by MALDI TOF mass spectrometry.
Methyltransferase assays
Methyltransferase assays were performed using peptide
substrates based on the histone H3 amino terminal se-
quence (ARTKQTARKSTGGKAPR-Y). For end-point
assays, H3 peptide concentration was 1 mM peptide, 0.5
mM SAM (including 0.625 mM 3H SAM [PerkinElmer])
in an assay buffer of 50 mMHEPES (pH 8), 200 mMNaCl
and 0.5 mM TCEP. Following separation of the peptide
from cofactor by C18 cartridge purification, the incorpora-
tion of 3H-labeled SAM into the peptide was estimated by
scintillation counting, as previously described (32). Methyl-
transferase assays were carried out at 30◦C for 60 min with
a final enzyme concentration of 10 M.
Methyltransferase assays with nucleosome substrate were
performed in a buffer containing 20 mM HEPES, pH
7.8, 200 mM NaCl, 2 mM dithiothreitol (DTT). Final
reagent concentrations were 5MMLL1 SET domain con-
struct (containing the WDR5 interacting motif), WDR5,
Ash2L and RbBP5 constructs, 100 M SAM and recom-
binant mononucleosome substrate with 147 bp containing
the 601 positioning sequence, prepared by the salt dial-
ysis method (33). Reactions were incubated at 30◦C for
2.5 h and stopped by addition of sodium dodecyl sul-
phate sample buffer. Following SDS-polyacrylamide gel
electrophoresis protein was transferred to Immobilon-PSQ
transfer membrane (Merck Millipore Ltd.) and blocked
with 5%milk solution. Membrane was probed with histone
H3K4 monomethyl-specific antibody (ab176877), (Abcam,
Cambridge, UK) at 1:10000 dilution in phosphate buffered
saline buffer with 0.05% Tween. The secondary antibody
was goat anti-rabbit conjugated to HRP at 1:5000 dilution
(Promega) and signal detected by autoradiography follow-
ing incubation with ECL reagent (Merck Millipore Ltd).
MALDI-TOF methyltransferase assays were performed
to examine the reaction products of the methyltransferase
reaction with the H3 peptide at specific time points as de-
scribed previously (34). The reaction mixture contained 10
M enzyme (MLL1 SET domain containing Win motif,
WDR5, Ash2L SPRY and RbBP5 1–380 or 325–380), 200
M SAM and 50 M unmodified H3 peptide at 30◦C for
up to 6 h. At various time points, aliquots of the reaction
were quenched by the addition of an equal volume of 1%
trifluoroacetic acid. Samples were diluted in a 1:5 ratio with
-cyano-4-hydroxycinnamic acid and analyzed on a Bruker
AutoFlex mass spectrometer (Bruker) in reflectron mode.
The reactions were performed in triplicate, and the propor-
tion of methyl species at each time point calculated by com-
bining these multiple measurements.
Downloaded from https://academic.oup.com/nar/article-abstract/46/7/3802/4948034
by University College London Library user
on 24 April 2018
Nucleic Acids Research, 2018, Vol. 46, No. 7 3805
Binding measurements
HPLC purified 14-mer DNA/RNA (GCATAGGTTCGA
TC-6FAM/GCAUAGGUUCGAUC-6FAM) labeled with
6-FAM fluorescein molecules were purchased from Sigma.
Equilibrium dissociation constants for the interaction of
RbBP5 (P) with FAM–RNA (L) to form the complex
RbBP5:RNA (PL) were determined using anisotropy titra-
tions. For any mixture of RbBP5 and FAM–RNA the ob-
served anisotropy (rOBS) is given by:
rOBS = αrPL[PL] + rL[L]
α[PL] + [L] (1)
where rPL and rL are the anisotropies of the complex and the
free nucleic acid, and α ( = 1 in this case) is the fluorescence
intensity of the complex divided by that of the free nucleic
acid. The data were analyzed using non-linear least-squares
fits to equation (1) with rPL, rL and the dissociation constant






2 & [L] = [L0] − [PL]
where the subscript 0 indicates the total concentration of
the species.
All anisotropy titrations were performed at 20◦C using a
Jasco FP-8500 fluorimeter. The buffer (50 mM Tris pH 7.4,
150 mMNaCl, 0.5 mMDTT). Measurements with dsRNA
and dsDNA were performed in identical conditions. Mea-
surements with RbBP5 mutants were performed as above
with dsRNA.
RESULTS
The RbBP5 -propeller domain is not essential for catalysis
The RbBP5 region covering residues 340–380, immediately
C-terminal to the -propeller domain, has been shown to
bind to other components of the catalytically active MLL
complex and to be essential for methylation (11). We were
first interested to determine if the -propeller domain con-
tributes to the activity of the assembled complex. We there-
fore compared the in vitro methyltransferase activity with
H3 peptide substrate for the MLL1 SET domain reconsti-
tuted with Ash2L/WDR5 and different RbBP5 constructs
(Figure 1). As expected theMLL1SETdomain alone exhib-
ited negligible methyltransferase activity, which only mod-
estly increased with addition of WDR5/Ash2L (SPRY)
(Figure 1B). However, the further addition of RbBP51–380
strongly stimulatedmethylation confirming the integral role
that this protein has in assembly of the catalytic core. In
line with the observation of Li et al. (11), a RbBP5325–380
construct also significantly stimulated activity, confirm-
ing that the elements responsible for assembling the com-
plex and stabilizing the active SET domain conformation,
are located in this region. However, interestingly, we ob-
served that the RbBP51–322 construct, in combination with
WDR5/Ash2L (SPRY), did not stimulate the overall ac-
tivity of MLL1, indicating that the -propeller domain
does not contribute significantly to the catalytic activa-
tion mechanism. The slightly higher activity observed for
RbBP51–380 compared toRbBP5325–380 may arise due to bet-
ter construct stability or improved complex integrity. The
equivalent methyltransferase assay, but using a recombi-
nant mononucleosome (147 bp DNA) substrate, showed a
similar pattern of MLL activation, i.e. activity was depen-
dent on the presence of the RbBP5325–380 region, but the -
propeller was not required (Figure 1C). This suggests that
the -propeller is neither essential for assembly of the cat-
alytically active complex or for recognition of core nucleo-
some.
The potency of histone methylation as an epigenetic sig-
naling mark lies in the high degree of specificity that recog-
nition domains exhibit for the number of methyl groups
on the methylated lysine. We were therefore interested to
determine if the presence of the -propeller domain had
an effect on the final reaction product. We compared
the product of the methyltransferase reaction with pep-
tide substrate using MALDI TOF analysis for the MLL1
(SET)/WDR5/Ash2L (SPRY) complexwithRbBP51–380 or
RbBP5325–380 constructs. In both cases the H3K4me1 and
to a lesser extent H3K4me2 product were readily detected,
consistent with the previously reported activity of the re-
constituted complex with peptide substrate (10,34) (Fig-
ure 1D). The amount of me2 product produced by the
RbBP5325–380 construct was slightly lower than the longer
construct, whichmay be attributed to amodest effect on the
overall stability of the complex, but these data indicate that
the RbBP5 -propeller does not significantly contribute to
catalytic activity and suggests that it has a different role.
Structure of the RbBP5 -propeller
To obtain a better understanding of the characteristics of
the WD40-repeat rich region, we determined the crystal
structure of mouse RbBP5. After screening a wide range
of constructs, diffracting crystals of the RbBP51–380 con-
struct were obtained, which contains both the -propeller
and the regions known to interact with other members of
theMLL complex. The structure was determined by molec-
ular replacement, for details see ‘Materials and Methods’
section, and refined to a resolution of 2.5A˚. The asymmet-
ric unit contains two copies of the construct (Figure 2A),
and data collection and refinement statistics are presented
in Table 1. The -propeller domain structure is basically
consistent between both copies, but the 325–380 region is
largely disordered and varies significantly. Differences arise
both in the course it takes with respect to the propeller, and
to the number of residues which could be built into inter-
pretable electron density. This can be interpreted as indica-
tive of an unstructured region, but one that adopts a con-
formation induced by the interaction with its binding part-
ners when assembled into the complex (11,22,24). The two
copies of the -propeller are linked in the crystal structure
due to a strand swap which disrupts the seventh blade of the
copy B propeller. The copy A residues 332–340 pack as a
parallel -strand against the copy B strand, displacing the
N-terminal residues 18–22, which completes the propeller
blade through the canonical interaction. This induces the
third strand in the blade to extend by four residues to Val
326. This organisation is most likely a crystallographic arte-
fact, notably we observed no dimerization in solution either
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Figure 2. Structure of the RbBP5 -propeller domain. (A) Cartoon representation of the RbBP5 asymmetric unit. The blades of the Copy A -propeller
are colored in alternating shades of blue. Copy B is colored in beige. The Copy A residues 332–340 displace the N-terminal strand in Copy B to form
a crystallographic dimer. (B) Top view of the RbBP5 -propeller showing a canonical arrangement of seven 4-stranded blades. A helical insert (pink) is
located at the interface of blades 4 and 5. (C) The RbBP5 central channel is formed from largely polar residues. (D) Cut-through of RbBP5 (electrostatic
surface representation) revealing the wide polar channel.
during purification or by Multi-Angle Laser Light Scatter-
ing (Supplementary Figure S3) analysis. In the analysis be-
low we focus on the -propeller of copy A, which represents
the physiological form of the propeller.
RbBP5 forms a canonical seven bladed WD40 repeat -
propeller in which the seventh blade is formed from three
anti-parallel strands from the C-terminal region of the do-
main and is completed with a strand originating from the
N-terminus of the domain (35) (Figure 2B). Between the
third and fourth strands of the 5th propeller blade there is
an insert which includes a short -helix, which lies on one
face of the propeller toward the rim (Figure 2B). Helical in-
serts are common in WD40 repeat proteins, and have been
observed in other chromatin associated -propellers, such
as RbAp48 and embryonic ectoderm development (EED),
where they are associated with protein interactions. For ex-
ample, in RbAp48 the helical insert on the side of the pro-
peller interacts with Histone H4 (36,37).
A conspicuous feature of the RbBP5 -propeller, which
appears to be quite distinct from other WD40 proteins in
chromatin modification complexes such as WDR5 in MLL
and EED and RbAp48 in PRC2, is that the central axis is
not formed from bulky aromatic side chains, but instead po-
lar residues dominate the propeller axis (Figure 2C). This
creates a much more open solvent filled channel of about
8A˚ diameter that links the two faces (Figure 2D). The top
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Rotamer Outliers 2.3 %
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channel edge is strongly basic, and at the ‘bottom’ the chan-
nel flares out creating a concave feature on that face of the
propeller. Potentially these patches could mediate targeting
interactions critical to the function of the MLL complex.
Both faces of the RbBP5 -propeller feature prominent
basic patches (Figure 3A and B). On the ‘top’ face, defined
as the face containing the -helical insert, the propeller axis
has a complete ring of basic side-chains, which extends into
a basic groove between blades six and seven, and so reaches
toward the edge of the propeller. These features arise from
Arginine and Lysine side-chains, with the central ring fea-
ture consisting of residues Arg34, 76, 118, 161, 162, 208
and Lys209 located on six of the seven blades (Figure 3C).
These residues are distributed across the primary sequence
of the domain and do not form a discrete motif; the residues
are conserved in the RbBP5 homologs from higher organ-
isms, only partially in Neurospora, but not at all in yeast
species (Figure 3C and E; Supplementary Figure S2). This
suggests that this feature may have evolved in multi-cellular
organisms, which is suggestive of a potential role in cell
lineage targeting, perhaps during developmental processes.
The bottom face of the -propeller is also characterized by
a basic patch (Figure 3B), which extends from one side of
the large cavity that surrounds the central axis to the edge of
the face (Figure 3D). These residues, Arg220, 251 272, and
294, and Lys 255, which form the basic batch on the bottom
surface are more broadly conserved across species, (Figure
3F and Supplemental Figure S2). In general, the bottom
face of the propeller is better conserved than the top (Fig-
ure 3E and F), which may indicate that it could mediate an
interaction that is fundamental to basic function.
Overall, the principal feature of the RbBP5 -propeller
surface, is that it is predominantly polar, both at the open
central axis and the basic patches that characterize both top
and bottom faces of the propeller. We were therefore inter-
ested to identify binding partners for this domain.
RbBP5 binds nucleic acids using an Arginine-rich surface
Given that the RbBP5 -propeller does not have a role in
modulating the activity of MLL1 we hypothesized that this
domain is most likely a platform for binding to unidenti-
fied partners involved in targeting the complex to chromatin
features or to specific genes. We explored whether the do-
main binds to histone tails using a biotin tagged RbBP5
-propeller construct to probe a histone peptide array con-
taining duplicates of 384 of the common epigenetic modifi-
cations (ActiveMotif), but no hits were identified using this
strategy (data not shown). Next, we reasoned that given the
basic characteristic of the features identified on the surface
of the -propeller, and the increasing evidence of involve-
ment of long non-coding RNA in targeting MLL1 (21,38),
it was plausible that the domain may recognize nucleic acid
rather than a protein partner.
To test RbBP5′s capability to bind nucleic acids we used
an NMR spectroscopy approach. NMR can deliver in-
formation on protein-ligand interactions covering a broad
range of affinities and is ideal for such a de novo exploration.
The 1H15N HSQC spectrum of the RbBP51–340 construct is
of a good quality considering the protein’s size. The reso-
nances are well dispersed and the peaks of relatively uni-
form intensity confirm that the protein is folded, soluble
and monomeric (Figure 4A). As no nucleic acid target of
the protein is known, we tested RbBP5 binding to both ss-
RNA, dsRNA and to dsDNA. We first titrated the protein
with a pool of short 7-nucleobase RNA oligos with random
sequence (7N-RNA). Titration of 7N-RNA shifted a subset
of resonances, indicating an interaction is taking place with
a discrete selection of RbBP5 residues (Figure 4B). The res-
onances are in fast exchange on a chemical shift timescale,
which is consistent with a dissociation constant in the mi-
cromolar range. Further, the small number of peaks chang-
ing chemical shift indicates that the contacts with backbone
moieties are not extensive and that it is likely that no major
structural rearrangement is taking place in theRbBP5 upon
associating with RNA. This is consistent with a surface fea-
ture such as those formed by the arginine side-chains.
Next, we examined whether the interaction with ssRNA
is sequence specific using ‘SIA’ (31). This method provides
the nucleobase preference of a protein domain for the differ-
ent positions of the bound RNA, and performs best at in-
termediate to low affinity and with transient protein–RNA
interactions. SIA was used to test the preference for each
nucleobase at five consecutive positions of a bound oligonu-
cleotide (Figure 4C). The SIA results indicate that RbBP5
has relatively little sequence specificity, with a very mod-
est preference for G and U. Consistently, an SIA optimized
RNA oligo (UAGGUUC) based on this preference bound
only marginally stronger to the RbBP5 -propeller than the
randomized oligo pool (Figure 4B and D).
Given that only a small number of RbBP5 resonance
shifts were observed upon addition of RNA and that the
nucleobase preference exhibited was very limited, we won-
dered whether the RbBP5–RNA interaction was mediated
with low specificity by a subset of the Arginine side chains
on the -propeller surface. In order to test this, we recorded
1H15N HSQC experiments optimized to capture changes
in the resonances of the Arginine side chain resonances
(Figure 5A). RNA titration results in the shift of a few of
the existing resonances and in the appearance of a num-
ber of new resonances. The strong effect of the RNA on
the linewidth of selected Arginine side chains is consistent
with the RNA interacting with the charged side chains of a
group of Arginines on the RbBP5 surface and slowing the
exchange of the 15N attached protons with the bulk water.
Next, we tested whether RbBP5 preferred DNA to
RNA or if a structural preference exists for ssRNA ver-
sus dsRNA.We recordedArginine-optimizedNMRexperi-
ments using 14-mer ssRNA, dsRNAand dsDNAmolecules
of the same sequence (except uracil were changed for
thymine in DNA) and length to titrate against RbBP51–340
(Figure 5B). The effect was strongest when titrating dsRNA
and weakest when titrating dsDNA, with the ssRNA hav-
ing an intermediate effect. To determine whether this ef-
fect can be correlated to a difference in binding affinity, we
performed a fluorescence anisotropy assay to measure equi-
librium dissociation constants for the binding of 6-carboxy
fluorescein labeled 14-mer oligos of ssRNA, dsRNA or ds-
DNA of identical sequence (Figure 5C). The anisotropy
measurements confirmed binding of all three nucleic acid
species, consistent with the NMR titrations. Further, also
consistent with the NMR titration RbBP5 showed a mod-
Downloaded from https://academic.oup.com/nar/article-abstract/46/7/3802/4948034
by University College London Library user
on 24 April 2018































Figure 3. Surface features of RbBP5. (A, C and E) Views of the ‘top’ of the RbBP5 -propeller, showing (A) Electrostatic surface of the ‘top’ face of the
-propeller. The position of the helical insert is indicated. (C) Cartoon representation of the ‘top’ face of the -propeller. The Arginine (magenta) and
Lysine (purple) side chains are shown, with the Arginine ring feature indicated by a blue ring. (E) Sequence conservation mapped onto the top face of
the -propeller (Gradient: green (conserved) to magenta (variable)). (B, D and F) Views of the ‘bottom’ surface of the propeller; (B) Electrostatic surface
of the ‘bottom’ face of the -propeller. (D) Bottom view of the propeller showing the Arginine (magenta) and lysine (purple) side chains. (F) Sequence
conservation mapped onto the ‘bottom’ face of the -propeller.
est preference for double stranded RNA (13.2 M), over
single stranded RNA (22.5 M) and double stranded DNA
(29.7 M). Overall our data indicate that RbBP5 recognize
dsRNAwith moderate affinity and structure specificity and
confirm that the interaction is mediated by Arginine side
chains.
Given that there are basic patches on both faces of the
-propeller, we were interested if nucleic acid binding was
limited to either face. Two candidate side chains were se-
lected from each patch and mutated to acidic residues. The
fluorescence anisotropy binding measurement was repeated
with dsRNA for wild-type -propeller and the four mu-
tant proteins (Figure 5D). Only modest changes in affinity
were observed for the single point mutants, which is consis-
tent with a broad interface. Both upper face mutants (R34E
and R162E) exhibited a greater than 2-fold loss of affinity,
whereas only one of the bottom face mutants (R220E) dif-
fered significantly from the wild-type. This limited evidence
favors a model in which the upper Arginine ring promotes
the interaction, but does not preclude the possibility that
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Figure 4. Analysis of RNAbinding to the RbBP5 -propeller. (A) 1H15NHSQC spectrum of the RbBP51–340 construct showing well-dispersed resonances.
(B) Titration of a randomized RNA 7-mer oligo nucleotide induces selective resonance shifts in the 1H15N HSQC spectrum. Blue apo RbBP5, orange
1:1, red 4:1 RNA:protein. (C) Scaffold Independent Analysis showing the preference of RbBP5 for each nucleobase at five consecutive positions in the
oligonucleotide. (D) Titration of a sequence optimised RNA 7-mer induces selective resonance shifts in the1H15N HSQC NMRspectrum of RbBP5.
with a larger nucleic acid substrate an interface involving
both surfaces may form, or that the faces may be involved
in independent interactions.
DISCUSSION
The MLL histone methylation complexes have two distinct
functions; one is the targeting function, and this is the role
of the major part of the MLL proteins themselves, as they
are essentially a series of recognition domains linked by
regions of predicted unstructured sequence. The other is
the catalytic function, comprising the complex formed by
the extreme C-terminal region of the MLLs and the four
WRAD complex proteins (9). The role of the RbBP5 re-
gion (residues 330–380) in organizing the activated com-
plex structure by linking Ash2L, WDR5 and the SET do-
main is well described (11,22,24,39). Our in vitro methyla-
tion data show that the main structural element of RbBP5,
the -propeller domain, does not play an integral role in
MLL complex assembly or catalytic activation. This sug-
gests that the RbBP5 -propeller may have a role in target-
ing the MLL/WRAD activity or even a function outside of
the MLL complex.
The other -propeller protein in the WRAD complex,
WDR5, has been shown to be a component ofmulti-protein
complexes independently of the other WRAD proteins or
MLL (40,41). For example, WDR5 is an integral compo-
nent of the histone acetyltransferase complexes NSL/MOF
where it binds to the NSL1 subunit (42) and the ATAC
complex (43). WDR5 is ubiquitously expressed and its high
abundance in the cytoplasm also suggests that it has roles
beyond chromatin modification complexes (44). There are
fewer examples suggesting that RbBP5 has such a varied
function. However, recent proteomic studies point to sev-
eral chromatin associated proteins that may potentially par-
ticipate in RbBP5 interactions in an MLL context, includ-
ing Chromo Helicase Domain 8 (45), Cfp1 (46), OGT (47)
and Cul4A-DDB1 (48), but further studies will be required
to determine if these are direct contacts.
Given that it does not appear to have a direct role in
formation of the catalytic core, the most likely function of
the RbBP5 -propeller could be in recruitment of MLL to
specific sites via modified chromatin. However, using a his-
tone modification peptide array consisting of a comprehen-
sive range of typical posttranslational modifications asso-
ciated with epigenetic signaling, we were unable to identify
any hits. It should be noted that this does not preclude that
RbBP5 could bind to histone tails in the context of an ex-
tended nucleosome arraywith linkerDNAor to an untested
combination of modifications. However, the prominent fea-
tures on the RbBP5 surface are basic patches, and it is un-
likely that the generally basic histone tails are interaction
partners.
Arginine ring or Arginine patch features occur in a range
of proteins, and in a number of cases have been shown to
interact with nucleic acid rather than proteins (49,50). For
example, the DDB2 -propeller has a surface patch of ba-
sic residues that bind to DNA through contacts with the
Downloaded from https://academic.oup.com/nar/article-abstract/46/7/3802/4948034
by University College London Library user
on 24 April 2018
3810 Nucleic Acids Research, 2018, Vol. 46, No. 7























10 9 8 7

















dsDNA 29.7 ± 4.2 0.056 0.143
dsRNA 13.2 ± 3.1 0.046 0.174
ssRNA 22.5 ± 3.2 0.039 0.179
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R220E 26.1 ± 2.8 0.066 0.146























Figure 5. RbBP5 binding to nucleic acids. (A) 1H15NHSQC spectrum of RbBP51–340 construct optimized for the detection of arginine side chain moieties,
indicated by red box at top. (B) Spectrum of RbBP5 free and titrated with ssRNA, dsRNA and dsDNA (orange apo RbBP5, blue 4:1 NA:protein). (C)
Fluorescence anisotropy measurements of RbBP51–340 binding to fluorescein labeled nucleic acid. (D) Fluorescence anisotropy measurements of acidic
mutants of RbBP51–340 binding to fluorescein labeled dsRNA.
phosphate backbone (51). This encouraged us to investi-
gate if we could detect direct binding of RNA to the RbBP5
-propeller. Our NMR and fluorescence anisotropy mea-
surements show that RbBP5 binds to nucleic acid via se-
lected Arginine side chains, consistent with the binding tak-
ing place in the large positive patch that surrounds one end
of the domains channel. Further, the experiments show a
modest preference of the protein for double stranded RNA
over single stranded RNA. This would be consistent with
a lncRNA, which are often structured, but as only modest
variations in affinity were observed with the different types
of nucleic acid, more experiments will be required to iden-
tify the physiological binding partner or partners.
There is growing evidence that at least part of the tar-
geting function of chromatin regulatory protein complexes
such as trithorax and polycomb group during develop-
ment is mediated by lncRNAs (52,53). The list of lncR-
NAs with a putative role in MLL mediated H3K4 methyla-
tion is expanding, and examples include HOTTIP, Mistral,
HoxBlinc and SnoRNA/116HG (20,54–57). Although the
site of interaction of many of these lncRNAs is unknown,
WDR5 has been implicated in some interactions (21).
However, there is some evidence supporting direct interac-
tion between RbBP5 and RNA. For example, depletion of
SnoRNA/116HG, a lncRNA, is linked to Prader-Willi syn-
drome. In a co-precipitation experiment with RbBP5 used
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as bait protein 116HG RNA was precipitated in conditions
that favored formation of RNA secondary structure (18).
RbBP5 has been identified as an RNA interacting protein
in two recent large-scale screens for novelRNAbinding pro-
teins (58,59). In one experimentRNAco-precipitatedwith a
peptide that corresponded to RbBP561–76. Notably, this re-
gion incorporates one of the Arginines associated with one
of the basic patches identified in our structural analysis.
Our structural analysis has revealed that the RbBP5 -
propeller has a feature rich surface that is likely to medi-
ate as yet unknown binding interactions. It is also likely
that, like its WRAD complex partner WDR5, the RbBP5
-propellermaymediate interactionswithmultiple partners
in different contexts. However, our binding analysis leaves
open the possibility that lncRNA is one potential partner.
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